Stay updated with breaking news from Opgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report sent to investors on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. Several other brokerages have also issued reports on PGEN. HC Wainwright restated a buy rating and issued a $6.00 target price on shares of […]
StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report published on Wednesday morning. The firm issued a hold rating on the medical research company’s stock. Separately, HC Wainwright downgraded shares of OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. View Our […]
Precigen, Inc. (NASDAQ:PGEN – Get Free Report) SVP Jeffrey Thomas Perez sold 8,741 shares of the firm’s stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $1.55, for a total value of $13,548.55. Following the completion of the sale, the senior vice president now owns 448,916 shares […]
Precigen, Inc. (NASDAQ:PGEN – Get Free Report) Director Steven Frank purchased 400,000 shares of Precigen stock in a transaction on Monday, August 14th. The shares were purchased at an average cost of $1.72 per share, with a total value of $688,000.00. Following the transaction, the director now owns 882,358 shares in the company, valued at […]
OpGen, Inc. (NASDAQ:OPGN – Free Report) – Investment analysts at HC Wainwright decreased their Q3 2023 earnings per share (EPS) estimates for shares of OpGen in a report issued on Monday, August 14th. HC Wainwright analyst Y. Chen now expects that the medical research company will post earnings per share of ($0.43) for the quarter, […]